Committees of the Board of Directors

There are six standing committees of the Johnson & Johnson Board of Directors:

  • Audit Committee,
  • Compensation & Benefits Committee,
  • Nominating & Corporate Governance Committee,
  • Finance Committee,
  • Public Policy Advisory Committee, and
  • Science & Technology Advisory Committee

See the descriptions provided below for each committee. For more information about the Audit, Compensation & Benefits and Nominating & Corporate Governance Committees, you may click on each heading to see that committee's charter.

To learn how the Johnson & Johnson Board of Directors make up each committee: Board Committee Chart

Audit Committee: comprised of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

  • Helps oversee the Company's accounting and reporting practices.
  • Recommends independent public accountants for appointment by the Board and reviews their performance.
  • Monitors adequacy of internal accounting practices, procedures and controls.
  • Reviews all significant changes in accounting policies.

Compensation & Benefits Committee: comprised of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

  • Establishes the Company's executive compensation philosophy and principles and approves the annual compensation and long-term incentives for the Company's directors and executive officers.
  • Reviews the philosophy and policies of the non-Board Management Compensation Committee with respect to executive compensation, perquisites and other compensation matters for non-executive employees.
  • Oversees the management of the various retirement, pension, long-term incentive, savings, and health and welfare plans that cover the Company's employees.

Finance Committee: comprised of the Chairman, Presiding Director and Vice Chairman of the Board, exercises the management authority of the Board during the intervals between Board meetings.

Nominating & Corporate Governance Committee: comprised of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

  • Oversees corporate governance matters.
  • Reviews possible candidates for Board membership and recommends nominees for election.
  • Oversees the process for performance evaluations of the Board and its committees.
  • Reviews the Company's management succession plans and executive resources.

Public Policy Advisory Committee: comprised of independent Directors and the Company's General Counsel and Vice Presidents for Corporate Affairs, Government Affairs and Policy and Worldwide Operations:

  • Reviews the Company's policies, programs and practices on public health issues regarding the environment and the health and safety of employees.
  • Reviews the Company's governmental affairs and policies and other public policy issues facing the Company.
  • Advises and makes recommendations to the Board on these issues as appropriate.

Science & Technology Advisory Committee: comprised of Board members and the Company's Vice President, Science and Technology

  • Advises the Board on scientific matters that include major internal projects; interaction with academic and other outside research organizations and acquisition of technologies and products.